News By: Gary Cramer

Psychedelic therapy is at a crossroads. It could be the transformative tool we need to help patients for whom existing treatments are not enough. However, if we take only a few steps down the wrong path, it could also become yet another almost-breakthrough. What can we do to ensure psychedelic therapy’s future?

A glimpse into some of the facts and figures at play in the comings and goings of today's clinical research enterprise.

In this article, the authors aim to raise awareness by illustrating varied career pathways in clinical research; to “get the word out” for those who are exploring first-level careers, for anyone looking at second-level careers, and for seasoned clinical research professionals who are exploring new opportunities.

The HIV/AIDS crisis in the United States and throughout the world devastated the gay and queer community and changed the world’s perspective on how clinical research is performed. A historical review of those who experienced the crisis from the beginning and what changes resulted from those events can provide valuable information for how the field of clinical research may continue to evolve.

Lisa Osborne interviews WCG executive Peter DiBiaso about his experiences as a drug development professional participating in clinical trials investigating new therapies for Parkinson’s disease.